Status:
COMPLETED
Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study
Lead Sponsor:
Fayoum University Hospital
Conditions:
Erectile Dysfunctions
Eligibility:
MALE
45-75 years
Phase:
PHASE4
Brief Summary
Introduction Sexual dysfunctions are annoying health problems with the erectile problems forming the main part of them. Erectile dysfunction (ED) is defined as the persistent inability to obtain or ma...
Detailed Description
Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study Introduction Sexual dysfunctions a...
Eligibility Criteria
Inclusion
- • Naive ( not previously treated) male patient with mild to moderate ED according to SHIM Questionnaire.
Exclusion
- ● Kidney disease or liver failure
- Coronary heart disease
- Peyronie's disease
- Neurological disease that may related to ED
Key Trial Info
Start Date :
January 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06947265
Start Date
January 14 2024
End Date
February 1 2025
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohamed Mahmoud Dogha
Al Fayyum, Keman Fares, Egypt, 63514